EvoNext Holdings SA (ELVAF)

Revenue by Product

Financials in millions CHF. Fiscal year is January - December.

Year Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Novel Food, Nutritional and Healthcare Ingredients Product-related	9.27M
Novel Food, Nutritional and Healthcare Ingredients Product-related Growth	-37.58%
Research & Development	170.50K
Research & Development Growth	-75.35%

Revenue by Geography

Financials in millions CHF. Fiscal year is January - December.

Year Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
United States	5.65M
United States Growth	-10.83%
Switzerland	3.79M
Switzerland Growth	-58.84%